Turkish Journal of Veterinary & Animal Sciences
Volume 38

Number 3

Article 2

1-1-2014

Course of hatch and developmental changes in thyroid hormone
concentration in blood of chicken embryo following in ovo
riboflavin supplementation
KAROLINA BARBARA TRZECIAK
MARCIN WOJCIECH LIS
ANDRZEJ SECHMAN
BARBARA PLYTYCZ
AGATA RUDOLF

See next page for additional authors

Follow this and additional works at: https://journals.tubitak.gov.tr/veterinary
Part of the Animal Sciences Commons, and the Veterinary Medicine Commons

Recommended Citation
TRZECIAK, KAROLINA BARBARA; LIS, MARCIN WOJCIECH; SECHMAN, ANDRZEJ; PLYTYCZ, BARBARA;
RUDOLF, AGATA; WOJNAR, TOMASZ; and NIEDZIÓLKA, JERZY WOJCCIECH (2014) "Course of hatch and
developmental changes in thyroid hormone concentration in blood of chicken embryo following in ovo
riboflavin supplementation," Turkish Journal of Veterinary & Animal Sciences: Vol. 38: No. 3, Article 2.
https://doi.org/10.3906/vet-1307-43
Available at: https://journals.tubitak.gov.tr/veterinary/vol38/iss3/2

This Article is brought to you for free and open access by TÜBİTAK Academic Journals. It has been accepted for
inclusion in Turkish Journal of Veterinary & Animal Sciences by an authorized editor of TÜBİTAK Academic
Journals. For more information, please contact academic.publications@tubitak.gov.tr.

Course of hatch and developmental changes in thyroid hormone concentration in
blood of chicken embryo following in ovo riboflavin supplementation
Authors
KAROLINA BARBARA TRZECIAK, MARCIN WOJCIECH LIS, ANDRZEJ SECHMAN, BARBARA PLYTYCZ,
AGATA RUDOLF, TOMASZ WOJNAR, and JERZY WOJCCIECH NIEDZIÓLKA

This article is available in Turkish Journal of Veterinary & Animal Sciences: https://journals.tubitak.gov.tr/veterinary/
vol38/iss3/2

Turkish Journal of Veterinary and Animal Sciences

Turk J Vet Anim Sci
(2014) 38: 230-237
© TÜBİTAK
doi:10.3906/vet-1307-43

http://journals.tubitak.gov.tr/veterinary/

Research Article

Course of hatch and developmental changes in thyroid hormone concentration in blood
of chicken embryo following in ovo riboflavin supplementation
1

1,

2

3

Karolina Barbara TRZECIAK , Marcin Wojciech LIS *, Andrzej SECHMAN , Barbara PŁYTYCZ ,
1
4
1
Agata RUDOLF , Tomasz WOJNAR , Jerzy Wojciech NIEDZIÓŁKA
1
Department of Poultry and Fur Animals Breeding and Animal Hygiene, University of Agriculture in Krakow, Krakow, Poland
2
Department of Animal Physiology and Endocrinology, University of Agriculture in Krakow, Krakow, Poland
3
Department of Evolutionary Immunology, Institute of Zoology, The Jagiellonian University, Krakow, Poland
4
Department of Animal Reproduction and Anatomy, University of Agriculture in Krakow, Krakow, Poland
Received: 18.07.2013

Accepted: 07.11.2013

Published Online: 21.04.2014

Printed: 20.05.2014

Abstract: The influence of riboflavin on the function of the hypothalamo–pituitary–thyroid axis during chicken embryogenesis is poorly
understood. Therefore, examination of the effects of in ovo riboflavin supplementation on the possible linkage between the thyroid gland
function and chick embryonic development seems to be interesting. Eggs on the sixth day of incubation were injected with 0 (control),
60, or 600 µg of riboflavin/egg. Blood samples were collected on the 12th, 15th, 18th, and 20th days of embryogenesis. Thyroxine (T4)
and triiodothyronine (T3) concentrations in plasma samples were determined by radioimmunoassay method. The time of external
pipping and hatching of each chick as well as the body weights of sampled and newly hatched chicks were recorded. Generally, riboflavin
supplied in ovo did not affect chicken embryo mortality and hatchability; however, a dose of 600 µg of riboflavin/egg had a tendency
to reduce embryo body weight. Chicks exposed to 60 µg of riboflavin/egg hatched 3.7 h earlier in comparison with controls and were
characterized by a higher synchronization degree of hatching. Both applied doses of riboflavin significantly elevated T4 concentrations
in blood plasma of the chicken embryos; however, on day 20 of embryogenesis, both applied doses of riboflavin decreased T3 levels in
blood circulation. The data presented here suggest that riboflavin supplementation at the early stages of embryogenesis markedly affects
embryonic development and influences thyroid hormone metabolism during the second half of embryogenesis.
Key words: Riboflavin, thyroid hormones, chick embryo

1. Introduction
Riboflavin (7,8-dimethyl-10-[(2S,3S,4R)-2,3,4,5-tetrahydr
oxypentyl]benzo[g]pteridine-2,4-dione, C17H20N4O6,
vitamin B2) plays a key role in energy metabolism as a
source of flavin mononucleotide (riboflavin-5′-phosphate,
FMN) and flavin adenine dinucleotide (FAD). Moreover,
it is a component of the flavin enzymes and coenzymes,
which carry electrons in oxidation and reduction
reactions, and it also plays a key role in the respiratory
chain and the oxidation of fatty acids and amino acids.
Furthermore, riboflavin is involved in the Krebs cycle
and the metabolism of folate, vitamin B6, (pyridoxine),
and vitamin B12 (cobalamin) (1). Riboflavin plays an
important role in the innate immunity of both plants and
animals (1–3). The immunomodulatory role of riboflavin
in avian immunity is particularly highly appreciated (3).
In vertebrates, flavin deficiencies lead to diseases
such as glossitis, cheilosis, and organic acidurias (4). A
deficiency of riboflavin is very rare in adult birds; however,
* Correspondence: rzlis@cyf-kr.edu.pl
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its disappearance from the organism is associated with the
overall hypovitaminosis (5–7). In avian species, riboflavin
is required for proper embryonic development; therefore,
it is accumulated in the developing chicken egg at an
amount of about 300 µg per egg (8). Riboflavin deficiency
is often related to mutations in an Rd gene encoding a
riboflavin-binding protein (RfBP), which is responsible
for deposition of riboflavin in eggs (9). In rd/rd mutants,
effects of deficiency become apparent after day 10 of
incubation (5). Embryo death occurs suddenly around
day 13 of incubation and is the result of inhibition of
activity of flavin-dependent enzymes, hypoglycemia, and
impaired fatty acid oxidation. The adverse effects of the Rd
gene mutation can be abolished by in ovo administration
of free riboflavin or FMN but not RfBP (10). Riboflavinsupplemented embryos survived and developed properly,
but those injected with RfBP died. This indicates that the
unbound riboflavin that is injected into egg whites can
be used by the developing embryo to ensure its proper
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development, while the injected apo-RfBP is detrimental.
The fates of embryos were dependent on the relative
amounts of the injected riboflavin and RfBP; excess of
the latter diminished the availability of riboflavin to the
chicken embryos, leading to their mortality (10).
In humans and other mammals, the relationship
between plasma concentrations of riboflavin and thyroid
hormones (THs) has been already described. It has been
established that 3,3’,5-triiodo-L-thyronine (T3) regulates
flavocoenzyme biosynthesis by determining the activities
of flavocoenzyme-forming enzyme (11,12). Possibly,
low concentrations of B vitamins adversely influence
the hypophysis, pituitary gland, and/or thyroid gland
functions (12).
The chicken embryo is the most useful and sensitive
model for drugs, xenobiotics, and vitamin investigations
(5,13–16). Nevertheless, in the available literature there are
no data showing the influence of riboflavin on the function
of the hypothalamo–pituitary–thyroid (HPT) axis during
chicken embryogenesis. Taking into consideration that
THs play a crucial role during chicken embryogenesis and
affect the time of hatching and the length of incubation
(17,18), the present study was designed to answer the
question of whether the supplementation of the chicken
embryo with riboflavin may change 3,3’,5,5”-tetraiodoL-thyronine (thyroxine; T4) and T3 levels in blood
circulation. Consequently, in this study the effects of this
vitamin on body and organ weight, as well as the hatching
parameters of embryo mortality and timing of external
pipping and hatching (during the last days of incubation),
were determined to find out the possible linkage between
the thyroid gland function (affected by riboflavin) and
embryonic development.
2. Materials and methods
2.1. Experimental design
The experimental and animal procedures were approved
by the Local Animal Ethics Committee in Krakow. Eggs of
the parental broiler line Ross 308 (Aviagen) were used in
the experiment. Before the start of incubation, eggs were
numbered and weighed. Incubation was carried out in an
incubator (Massales 65, Spain) under standard conditions
(temperature of 37.8 °C; relative humidity of 50%), and
eggs were turned once an hour at an angle of 90° during
days of incubation from days 1 to 18 (E1–E18). During
incubation, eggs were candled on days 6, 8, and 18 (E6,
E8, and E18). During E6 candling, eggs with unfertilized
and dead embryos were discarded, while in E8 candling,
embryos that died after injection were removed. On
E18, candled eggs with evidence of living embryos were
transferred from the turning trays into hatcher baskets and
incubation was continued at 37.2 °C and 55%–65% relative
humidity.

The sixth day of incubation was considered optimal to
carry out in ovo supplementation according to previous
experiments and publications (13–15), in order to reduce
the sensitivity of the embryo to manipulation and to ensure
the action of administered substances for the longest
period. Eggs candled on E6 with living embryos (n = 600)
were divided into 3 equal groups, which were injected with
riboflavin at doses of 0 (control), 60, or 600 µg/egg. The
lower dose of riboflavin was based on the publication of
Lee and White (10) as a minimum quantity of this vitamin
sufficient for the proper development of the chick embryo,
while the higher dose exceeds by about 2 times the amount
of riboflavin contained in the chicken egg (8).
Riboflavin (R9504, Sigma, USA) was dissolved in 50
µL of sterile 0.7% NaCl solution (Polpharma SA, Poland).
Before the injection, the shell at the site of the injection
was disinfected with 70% ethanol and a window was made
in the eggshell (diameter of about 5 mm). Injection was
performed using a pipette with 100 µL volume tips via the
air chamber at a depth of 5 mm under the chorioallantoic
membrane to the albumin without injuring the blood
vessels and the amnion. The riboflavin solution was stored
in a light-impervious vessel. After injection, the hole was
sealed with Parafilm tape (Sigma) and eggs from every
group were subsequently divided to into 2 subgroups:
1) a “hatchability” subgroup for checking hatchability
and course of hatch (n = 145 eggs per group) and 2) a
“sampling” subgroup for tissue sampling (n = 55 per
group). Incubation was then continued under normal
conditions.
2.2. Hatching course and result of hatch analyses
All eggs discarded during candling or unhatched from
the “hatchability” subgroups were analyzed for the stage
of development and malformations. Moreover, on E18
candled eggs from these subgroups with evidence of living
embryos were transferred to hatching baskets and used to
monitor the course of the hatching process. The process
of hatching was checked every 2 h from the 460th hour
of incubation. The time of external pipping and the time
of hatching of each chick were recorded. At the end of the
experiment, the unhatched eggs were broken and the stage
of embryonic development was noted (8,19).
2.3. Blood sampling, body and organ weight recording,
and hormone analysis in plasma
Blood samples were collected from 12 randomly selected
embryos of each “sampling” subgroup on E12, E15, E18
(stage before internal pipping), and E20 (stage of external
pipping). Blood was sampled into test tubes with heparin
(Coaparin, Polfa Warsaw Ltd., Poland). Plasma samples
were kept at –20 °C until hormone determination. After
blood collection, each embryo was drained and body
weights were recorded. Subsequently, the heart and liver
were dissected and weighed.
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embryos during the incubation process, which is in
agreement with previous findings (20), the data from both
sexes were combined. The results were presented as mean
± SEM and were considered significant at P ≤ 0.05 and
highly significant at P ≤ 0.01.

Thyroid hormone T4 and T3 concentrations in plasma
samples were determined by means of radioimmunoassay
using T4 and T3 kits (BRAHMS, Germany). The lowest
limits of T4 and T3 assay sensitivity were 0.7 ng/mL and
0.09 ng/mL, and mean recoveries as performed in our
laboratory were 96.3% and 95.0%, respectively. The
intra- and interassay coefficients of variation for T4 and
T3 analysis were 4.0% and 5.3%, and 3.5% and 6.3%,
respectively. The cross-reactions of T4 antibodies with
T3 and rT3 (3,3’,5’-triiodo-L-thyronine) were <0.2% and
5%, respectively, while with other iodothyronines and
iodothyronine-like compounds they were below 0.5%.
The cross-reaction of T3 antibodies with T4 was 0.06%,
and with other iodothyronines and iodothyronine-like
particles it was below 0.2%.

3. Results
3.1. Embryo hatchability and mortality
Generally, in comparison with the control group, riboflavin
supplied in ovo did not affect chicken embryo mortality
and hatchability, except at the dose of 60 µg/egg. In this
case, many embryos died immediately after manipulation
(between E6 and E8), resulting in a decrease in hatchability
by 11% (P ≤ 0.05; Table 1).
ANOVA revealed that the embryonic body weight
(EBW) was significantly influenced by stage of development
(P ≤ 0.01) and riboflavin administration (P ≤ 0.05). The
first effect was evoked by a gradual increase in EBW from
9.5 ± 0.25 g on E12 to 38.4 ± 0.90 g on E20 in the control
group. The second was a result of a significant reduction
of EBW by the higher dose of riboflavin (600 µg/egg) by
11% and 10% (P ≤ 0.05) on E12 and E15, respectively
(Figure 1). The relationship between the EBW and stage of
embryogenesis and dose of riboflavin can be described by
the following equation: y = –35.496 + 3.606x – 0.003z, R2
= 0.927, where: y is the body weight of the embryo, x is the
day of incubation, and z is the dose of riboflavin.
The weight of the liver and the heart gradually increased
in all groups during embryogenesis (P ≤ 0.01), but there
was no significant effect of riboflavin administration on
the weight of these tissues, nor on their relative weight (P
> 0.05; data not shown).
3.2. Course of hatching
Riboflavin treatment did not affect the time of external
pipping (Table 2). However, statistical analysis of the
course of hatching revealed that chicks exposed to 60 µg

2.4. Statistical analyses
Results of the pipping and hatching courses were presented
as medians and means ± SDs and were analyzed by the
Kruskal–Wallis one-way analysis of variance (ANOVA) on
ranks for failed normality test. Data of each group were
demonstrated with a linear regression of y = a + bx, where y
is percentage of the pipped/hatched chicks; x stands for the
incubation hour; a is the intercept, i.e. the estimated start
of the pipping or hatching process; and b is the slope, i.e.
the degree of the synchronization of pipping or hatching
processes in the time (h) necessary to pip or hatch 1% of
the chicks (14,15).
The hatchability and mortality data were statistically
analyzed by z-test while the results of TH concentrations
as well as body and organ weight were studied by 2-way
ANOVA, followed by Tukey’s multiple range test.
The statistical analyses were performed using SigmaStat 2.03 (SPSS, USA) while figures were made with
Grapher 8.0 (Golden Software Inc., USA). Because the
radioimmunoassay revealed that there were no significant
differences in plasma TH levels between male and female

Table 1. Effect of in ovo injection of riboflavin at day 6 of incubation on embryonic mortality and chicken hatchability.
0

Dose of riboflavin (µg per egg)

n

%

145

E6–E8

Hatchability

%

n

%

100.0

145

13

9.0

a

100.0

145

100.0

30

20.7

9

6.2a

E9–E17

11

7.6a

13

9.0a

14

9.7a

E18–E21

8

5.5a

5

3.4a

4

2.8a

113

77.9a

97

66.9b

118

81.4a

a, b: values in rows marked with different letters differ significantly (P ≤ 0.05).
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f

Control

f

f

60 µg riboflavin/egg
60 µg riboflavin/egg

body we ig ht [g ]

30

20

c

10

a

0

a

c

e

e e

d

b

E 12

E 15
E 18
Da y o f inc ub a tio n

E 20

Figure 1. Body weight of chick embryos treated in ovo with
riboflavin at day 6 of incubation (mean ± SE; n = 12). a, b, c,
d, e, f: values in same plots marked with different letters differ
significantly (P ≤ 0.05).

of riboflavin per egg hatched 3.7 h earlier than controls
(P ≤ 0.05; Table 2). This was caused by a shorter length of
hatching by 2.1 h (P ≤ 0.05; Table 2). Moreover, chicks from

this group demonstrated a higher synchronization degree
of hatching process in comparison with the controls (P ≤
0.05; Table 2). Regression equations revealed that 1% of
chicks treated with 60 µg of riboflavin needed 11.4 min
for pipping and 7.2 min for hatching, while chicks of the
control group needed 13.2 and 13.8 min, respectively
(Table 2). Administration of riboflavin at a dose of 600 µg
did not influence hatching indicators.
3.3. Hormone concentration in blood plasma
Concentration of T4 in blood plasma of chicken embryos
on E12 and E15 was relatively low; however, it significantly
increased from E18 (P ≤ 0.01; Figure 2a). In the control
group, on E12 it was 1.88 ± 0.13 ng/mL, and it did not
change on E15 (Figure 2a). On E18, the plasma level of T4
sharply increased, reaching a value that was 4.9-fold higher
in comparison with E15 (P ≤ 0.01). An additional elevation
in T4 plasma concentration was observed on E20, as it was
1.2-fold higher in comparison to E18 (P ≤ 0.05; Figure 2a).
Both applied doses of riboflavin significantly elevated T4
concentrations in the blood plasma of the chicken embryo
on E15 by about 60% (P ≤ 0.01). The stimulatory effect of
riboflavin was also found on E18 and E20; however, only
the higher dose of riboflavin effectively increased (by 24%
and 23%, respectively) T4 concentrations (P ≤ 0.05; Figure
2a). On the other hand, the lower dose of riboflavin (i.e. 60
µg/egg) significantly reduced T4 levels on E12 by 16% (P ≤
0.05; Figure 1a).

Table 2. Effect of in ovo injection of riboflavin at day 6 of incubation on the hatching process.
Time of stage
(hour of incubation)

Estimated start
of stage (a ± Sa)

Degree of the
synchronization
(b± Sb)

n

median

mean ±SE

(hour of incubation)

(h)

0

117

468a

467.6 ± 0.89a

456.4 ±0.50a

0.22 ± 0.008a

60

99

464a

466.5 ± 0.85a

457.1 ±0.50a

0.19 ± 0.008ab

600

120

468a

469.2 ± 1.97a

457.5 ±0.48a

0.23 ± 0.008a

0

113

476b

477.1 ± 0.93b

465.5 ±0.43b

0.23 ± 0.020a

60

97

472b

473.4 ± 0.62c

467.1 ±0.54b

600

118

480b

478.8 ± 0.89b

467.8 ±0.49b

0.22 ± 0.010a

0

113

8c

9.0 ± 0.46d

-

-

60

97

8

e

6.9 ± 0.66

-

-

600

118

8c

9.8 ± 0.46d

-

-

Stage of

Dose of
riboflavin

hatching

(µg/egg)

External pipping (EP)

Hatching (H)

Length of hatching
(DH = H – EP, h)

c

0.12 ± 0.030bc

Course of chicken hatching was estimated with linear regression y = a + bx, where y is percentage of the pipped/hatched chicks; x stands
for the incubation hour; a is the intercept, i.e. the estimated start of pipping or hatching process; b is the slope, i.e. the degree of the
synchronization of pipping or hatching processes in the time (h) necessary to pip or hatch 1% of chicks; Sa is the error of intercept; and
Sb is the error of slope.
a, b, c, d: values in columns marked with different letters differ significantly (P ≤ 0.05).
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- Control

- 60 µg riboflavin/egg

- 600 µg riboflavin/egg

5

15
a)

b)

e
d

d

4

d

e
e

T4 [ng /ml]

T3 [ng /ml]

10

c

f

c

3

2

5

d

a

b
a a

a

b

c b

1

c

c

d d

a

a

0

0

E 12

E 15

E18

E20

E 12

E 15

Da y o f inc ub a tion

E 18

E 20

Da y o f inc ub a tio n
0.6

f

c)

f
f
e
0.4

ef
e

T3 / T4

d

d

c
0.2

b

b
a

0
E 12

E 15

E18

E20

Da y o f inc ub a tion

Figure 2. Concentration of thyroxine (T4) (a), concentration of triiodothyronine (T3) (b), and the molar ratio of T3 to T4 (c) in blood
plasma of chicken embryos treated in ovo with riboflavin at day 6 of incubation (mean ± SE; n = 12). a, b, c, d, e, f: values in same
plots marked with different letters differ significantly (P ≤ 0.05).

In the control group, the plasma concentration
of T3 was 0.90 ± 0.06 ng/m: on E12 (Figure 2b). It was
significantly decreased (1.45-fold) on E15 (P ≤ 0.05), and
subsequently, on E18, it rose by 1.8-fold in comparison to
E15 (P ≤ 0.01). A sharp increase (2.9-fold in comparison
with E18; P ≤ 0.01) in T3 concentration in blood plasma
of chicken embryos was observed on E20 (Figure 2b).
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A lower dose of riboflavin (i.e. 60 µg/egg) reduced the
T3 level by 13% (P ≤ 0.05) on E12; on the other hand, it
elevated concentration of this hormone by 44% on E15 (P
≤ 0.01; Figure 2b). There were no significant alterations in
T3 levels on E18; however, on E20 both applied doses of
riboflavin decreased T3 levels in blood circulation by 27%
(P ≤ 0.01) and 19% (P ≤ 0.05), respectively (Figure 2b).
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The molar T3/T4 ratio is presented in Figure 2c. In the
control group, a gradual decrease in T3/T4 ratio from 0.49
± 0.03 on E12 to 0.15 ± 0.02 on E18 was observed (P ≤
0.01). A sharp 2.8-fold increase in T3/T4 was found on
E20 (P ≤ 0.01). The higher dose of riboflavin significantly
reduced the T3/T4 ratio on E15, E18, and E20 by 46% (P ≤
0.01), 16% (P ≤ 0.05), and 20% (P ≤ 0.05), respectively. On
E20 the lower dose of riboflavin also decreased the molar
ratio of T3/T4 by 19% (P ≤ 0.05; Figure 2c).
4. Discussion
The results of this experiment reveal that the injection of
riboflavin at the beginning of embryogenesis may disturb
the course of chick embryo development. It was found
that only the lower dose of riboflavin (i.e. 60 µg) decreased
hatchability by 11%, which was evoked by a significant
elevation in embryonic mortality (by 20.7%) from 1–2
days following the manipulation. Taken together with the
fact that the mortality among the 3 groups did not differ
on the following days, this suggests that the observed effect
could also be due to an uncontrolled external factor rather
than embryo toxicity. This explanation can be supported
by fact that the sensitivity of the chicken embryo to in ovo
manipulation is very high at early stages of embryogenesis
and it decreases gradually during embryonic development.
It is thought that disturbance in embryo homeostasis
caused by the applied in ovo manipulation is the main
reason for its mortality (13). Nevertheless, results of
experiments performed by Lee and White (10) indicate
that the fate of an embryo is dependent on the proper ratio
of RfBP and free riboflavin. In ovo manipulation might
disturb this ratio, and the temporal excess of apo-RfBP
might be detrimental to embryos. We may speculate that
this is one of the reasons for mortality of embryos injected
with saline or riboflavin during the present experiments.
Perhaps the low dose of exogenous riboflavin predisposes
RfBP to diminish its binding properties.
Several lines of evidence indicate that a reduction in
body weight during the pre- and postembryonic period
and in chickens (6,21) is associated with a riboflavin
deficiency. In sharp contrast, in our experiment the
highest dose of riboflavin (i.e. 600 µg/egg) substantially
decreased the weight of the chick embryo. A reduction
in gains was also observed in the growing broiler chicken
supplemented in ovo with 1.5 and 3 mg of riboflavin
(22). It cannot be excluded that the reduction in body
weight following riboflavin treatment is associated with
an increase in the basal metabolic rate as a result of
elevation in the activity of flavin-dependent enzymes (i.e.
flavoprotein monooxygenases, acyl-CoA dehydrogenases,
or cytochrome P450 reductase) (1). Moreover, riboflavin
is a cofactor in the conversion of pyridoxine (vitamin B6)
to pyridoxal phosphate. It seems to be likely that an excess
of riboflavin accelerates depletion of available pyridoxine.

Deficiency of vitamin B6 can also be a cause of chicken
BW loss (21).
The statistical analysis of the course of pipping and
hatching reveals that the elevation in riboflavin availability
on E6 may affect the rate of hatching. It can be assumed
that this is related to changes in the embryonic metabolism
associated with alterations in TH concentration in blood
circulation. It is well known that THs play an important
role in the development of many systems in all vertebrates,
including birds (23,24). The rapid increase in T3 at the
end of incubation is necessary not only for stimulation of
growth and differentiation, but also for preparation of the
chick for a life outside the egg by regulating processes such
as yolk sac retraction, the onset of pulmonary respiration,
hatching, and the initiation of endothermic responses
(25,26). The low T3 concentration observed during
most of embryogenesis is a result of high activity of D3
deiodinase, which in the liver and kidney converts T3 to
3,3’-diiodo-L-thyronine (3,3’-T2). A sharp increase in T3
concentration, which appears slightly later in comparison
with the peak of T4, occurring during the hatching period,
is associated with the transition of the chick embryo from
chorioallantoic to pulmonary respiration. It is associated
with a decrease in activity of D3 deiodinase and elevation
in activity of D1 deiodinase, which metabolizes T4 to T3
(23,24).
In the present experiment alterations in TH
concentration correspond with the changes described
above; however, it should be noted that the release of T4
from the thyroid gland into the blood circulation during
hatching (i.e. on E20) in the group treated with riboflavin
at a dose of 600 µg/egg was significantly higher in
comparison with the control group. On the other hand, at
the moment of pipping, the concentrations of T3 in blood
plasma in both experimental groups were significantly
lower than in the control group. It can be concluded that
the observed changes in T4 levels are the result of HPT
axis activity under the influence of riboflavin and changes
in the metabolism of this hormone in peripheral tissues
such as the liver. Recently, Grommen et al. (27) revealed
that the elevated plasma T4 levels observed during the
last trimester of chicken embryogenesis associated
with the increased synthesis and secretion of T4 by the
thyroid gland are caused by the increase in thyroglobulin,
sodium/iodine symporter, and thyroid peroxidase mRNA
expression. Therefore, the increased concentration of T4
on E18 and E20 in the group treated with the highest dose
of riboflavin might be connected with a direct influence of
this vitamin on expression of thyroid-specific genes. Nor
can it be excluded that the increase in T4 concentration
with a concomitant decrease in T3 level could be evoked by
the elevation in the iodotyrosine deiodinase (IYD) activity
as a result of increased availability of FMN as a cofactor
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for this enzyme. The IYD is the only flavin-dependent
deiodinase that facilitates the recovery of iodide in the
thyroid tissue by catalyzing deiodination of mono- and
diiodotyrosine (28,29). However, in order to verify this
hypothesis, further studies are needed.
Because in avian species almost all circulating T3 is of
peripheral origin (24), it can be assumed that the changes
in T3 levels following the riboflavin administration are
the result of its impact on the activity of D1 and D3
deiodinases. The decrease in T3/T4 ratio in the blood of
embryos treated with vitamin B2 supports this assumption
and suggests that riboflavin directly increases the activity
of D3 deiodinase in the final stages of embryogenesis.
The existence of the specific relationship between
riboflavin and thyroid gland function observed in our
experiment has already been postulated. In mammals, it
has been shown that there is a correlation between the
levels of riboflavin and concentration of iodothyronines
in the blood circulation. In humans and rats with
hypothyroidism, FAD levels decrease in the liver; they
are similar to those observed in animals fed a vitamin
B2-deficient diet. This phenomenon results from the T4related activity of flavokinase, the enzyme responsible
for the conversion of vitamin B2 into FMN and FAD.

Although in the hyperthyroid state the activity of this
enzyme is doubled, there is no increase in the level of
FMN and FAD as a result of their increased expenditure
(30). Therefore, hormone replacement therapy in adults
with hypothyroidism normalizes the metabolism of
riboflavin. However, this treatment in newborns with
congenital thyroid dysfunction does not change the levels
of vitamin B2 and FMN in the blood, in spite of obtaining
the appropriate level of iodothyronines (30).
In summary, riboflavin administration at the early stages
of embryogenesis markedly affects embryonic development
and influences thyroid hormone metabolism during the
second half of embryogenesis. Negative effects of riboflavin
on hatching success in the present experiments seem to be
related to the early timing of its administration. Beneficial
effects of riboflavin on posthatch immunity may be
expected in birds supplemented in ovo at the final stages of
development, as has happened in the case of vitamin E (3). In
order to understand the molecular mechanism of riboflavin
action in the chicken embryo, more research is needed
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